Evaluation of all three pinniped families to triannual vaccination with an inactivated rabies vaccine

A recent outbreak of rabies virus has been identified as an emerging epidemic among Cape fur seals ( Arctocephalus pusillus pusillus ) along the southern African coastline. This marks the first large-scale detection of rabies virus in marine mammals and raises significant concerns about potential transmission to other mammals and humans. There is also growing apprehension about the virus’s capacity to spread across national and continental borders, with a potential spillover event occurring into the sub-Antarctic region. Vaccination of wild populations would be a cornerstone to controlling this outbreak. This study investigated whether pinnipeds housed at Ocean Park Corporation (OPC) in Hong Kong developed an immune response to a commercially available inactivated rabies vaccine (Rabisin ® and Nobivac ® ). Sixteen pinnipeds, representing all three pinniped family groups including Californian sea lion ( Zalophus californianus ), Pacific walrus ( Odobenus rosmarus ), Harbor seal ( Phoca vitulina ), and Spotted seal ( Phoca largha ), received a 1 mL dose of an inactivated parenteral vaccine every three years. Historical serum samples collected over five years during routine health examinations were analyzed to assess the duration of the vaccine-induced immune response. The antibody titers indicated that all individuals seroconverted and remained seropositive following vaccination. Although antibody titers declined before administration of the second vaccine dose at the three-year interval, all recorded values remained above the 0.5 IU/L threshold considered indicative of an adequate (presumed protective) immune response to rabies vaccination. The study concluded that the parenteral vaccine was safe for use across all three pinniped families in the species studied and that a single dose provided protective immunity for approximately three years, after which booster vaccination was recommended.

Authors

Institutions

Publication Details

Journal
Frontiers in Marine Science
Published
2026-11-16
DOI
https://doi.org/10.3389/fmars.2026.1998517
Primary Topic
Rabies epidemiology and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of all three pinniped families to triannual vaccination with an inactivated rabies vaccine

Brett R. Gardner, Chris M. Perkins, Ilse Jenkinson, Drienie Claassen et al.
2 links
Frontiers in Marine Science
Rabies epidemiology and control
article

Evaluation of all three pinniped families to triannual vaccination with an inactivated rabies vaccine

Brett R. Gardner, Chris M. Perkins, Ilse Jenkinson, Drienie Claassen, Paolo Martelli, Mmantshuruge Miyen
article en

Abstract

A recent outbreak of rabies virus has been identified as an emerging epidemic among Cape fur seals ( Arctocephalus pusillus pusillus ) along the southern African coastline. This marks the first large-scale detection of rabies virus in marine mammals and raises significant concerns about potential transmission to other mammals and humans. There is also growing apprehension about the virus’s capacity to spread across national and continental borders, with a potential spillover event occurring into the sub-Antarctic region. Vaccination of wild populations would be a cornerstone to controlling this outbreak. This study investigated whether pinnipeds housed at Ocean Park Corporation (OPC) in Hong Kong developed an immune response to a commercially available inactivated rabies vaccine (Rabisin ® and Nobivac ® ). Sixteen pinnipeds, representing all three pinniped family groups including Californian sea lion ( Zalophus californianus ), Pacific walrus ( Odobenus rosmarus ), Harbor seal ( Phoca vitulina ), and Spotted seal ( Phoca largha ), received a 1 mL dose of an inactivated parenteral vaccine every three years. Historical serum samples collected over five years during routine health examinations were analyzed to assess the duration of the vaccine-induced immune response. The antibody titers indicated that all individuals seroconverted and remained seropositive following vaccination. Although antibody titers declined before administration of the second vaccine dose at the three-year interval, all recorded values remained above the 0.5 IU/L threshold considered indicative of an adequate (presumed protective) immune response to rabies vaccination. The study concluded that the parenteral vaccine was safe for use across all three pinniped families in the species studied and that a single dose provided protective immunity for approximately three years, after which booster vaccination was recommended.

Frontiers in Marine ScienceVol. 13
The University of Melbourne (AU), Onderstepoort Veterinary Institute (ZA), Melbourne Health (AU)
Good health and well-being
Rabies epidemiology and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon